SELLAS Life Sciences Group, Inc. Proceeds from Long-Term Debt Issued
SELLAS Life Sciences Group, Inc. (SLS) reported Proceeds from Long-Term Debt Issued of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2018-04-13
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2017-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2017-06-30 was -$4.45M, a 118.82% decline year-over-year.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2017-03-31 was $4.45M.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for the quarter ending 2016-12-31 was -$22.14M.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for fiscal 2016 was $1.50M.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for fiscal 2015 was $0.00.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- SELLAS Life Sciences Group, Inc. proceeds from issuance of long-term debt for fiscal 2013 was $9.87M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed | Proceeds from Issuance of Long-term Debt 126 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$4.45M derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | -$22.14M derived: sum of 4 quarters · filed 2018-04-13 | ||
| 2017-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | -$22.14M derived: sum of 3 quarters · filed 2018-04-13 | -$22.14M derived: sum of 4 quarters · filed 2018-04-13 | ||
| 2017-03-31 | $4.45M 10-Q · filed 2017-05-10 | -$17.69M derived: sum of 2 quarters · filed 2018-04-13 | -$17.69M derived: sum of 3 quarters · filed 2018-04-13 | $5.95M derived: sum of 4 quarters · filed 2018-04-13 | ||
| 2016-12-31 | -$22.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-13 | -$22.14M derived: sum of 2 quarters · filed 2018-04-13 | $1.50M derived: sum of 3 quarters · filed 2018-04-13 | $1.50M 10-K · filed 2018-04-13 | $23.40M 10-K · filed 2017-03-15 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $23.64M derived: sum of 2 quarters · filed 2017-11-09 | $23.64M 10-Q · filed 2017-11-09 | $23.64M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $23.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $23.64M 10-Q · filed 2017-08-14 | $23.64M derived: sum of 3 quarters · filed 2017-08-14 | $23.64M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-05-10 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $0.00 10-Q · filed 2014-11-05 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | |||||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-04-15 | $0.00 derived: sum of 2 quarters · filed 2016-04-15 | $9.87M 10-K/A · filed 2016-04-15 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $9.87M 10-Q · filed 2014-11-05 | ||||
| 2013-06-30 | $9.87M 10-Q · filed 2014-08-11 | $9.87M 10-Q · filed 2013-08-09 | ||||
| 2012-12-31 | $0.00 derived: 8-K 12 month − 10-Q/A 9 month · filed 2015-12-04 | $0.00 derived: sum of 2 quarters · filed 2015-12-04 | $0.00 8-K · filed 2015-12-04 | |||
| 2012-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 10-Q/A · filed 2013-11-07 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | |||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |